These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3577206)

  • 1. Polymorphism of human cytochrome P-450.
    Guengerich FP; Umbenhauer DR; Churchill PF; Beaune PH; Böcker R; Knodell RG; Martin MV; Lloyd RS
    Xenobiotica; 1987 Mar; 17(3):311-6. PubMed ID: 3577206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidation of quinidine by human liver cytochrome P-450.
    Guengerich FP; Müller-Enoch D; Blair IA
    Mol Pharmacol; 1986 Sep; 30(3):287-95. PubMed ID: 3748010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a rat liver cytochrome P-450UT-H cDNA clone and comparison of mRNA levels with catalytic activity.
    Churchill PF; Churchill SA; Martin MV; Guengerich FP
    Mol Pharmacol; 1987 Feb; 31(2):152-8. PubMed ID: 3543648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction.
    Shimada T; Misono KS; Guengerich FP
    J Biol Chem; 1986 Jan; 261(2):909-21. PubMed ID: 3079764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.
    Guengerich FP; Martin MV; Beaune PH; Kremers P; Wolff T; Waxman DJ
    J Biol Chem; 1986 Apr; 261(11):5051-60. PubMed ID: 3514607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism.
    Larrey D; Distlerath LM; Dannan GA; Wilkinson GR; Guengerich FP
    Biochemistry; 1984 Jun; 23(12):2787-95. PubMed ID: 6432035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.
    Srivastava PK; Yun CH; Beaune PH; Ged C; Guengerich FP
    Mol Pharmacol; 1991 Jul; 40(1):69-79. PubMed ID: 1857342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.
    Distlerath LM; Reilly PE; Martin MV; Davis GG; Wilkinson GR; Guengerich FP
    J Biol Chem; 1985 Jul; 260(15):9057-67. PubMed ID: 4019462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase.
    Ged C; Umbenhauer DR; Bellew TM; Bork RW; Srivastava PK; Shinriki N; Lloyd RS; Guengerich FP
    Biochemistry; 1988 Sep; 27(18):6929-40. PubMed ID: 3196692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons.
    Shimada T; Martin MV; Pruess-Schwartz D; Marnett LJ; Guengerich FP
    Cancer Res; 1989 Nov; 49(22):6304-12. PubMed ID: 2509067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of a rat liver cytochrome P-450 induced by pregnenolone 16 alpha-carbonitrile and other compounds in the 4-hydroxylation of mephenytoin.
    Shimada T; Guengerich FP
    Mol Pharmacol; 1985 Aug; 28(2):215-9. PubMed ID: 4022003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
    Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
    Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450.
    Guengerich FP
    Mol Pharmacol; 1988 May; 33(5):500-8. PubMed ID: 3285175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme.
    Waxman DJ; Attisano C; Guengerich FP; Lapenson DP
    Arch Biochem Biophys; 1988 Jun; 263(2):424-36. PubMed ID: 3259858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human-liver cytochromes P-450 involved in polymorphisms of drug oxidation.
    Guengerich FP; Distlerath LM; Reilly PE; Wolff T; Shimada T; Umbenhauer DR; Martin MV
    Xenobiotica; 1986 May; 16(5):367-78. PubMed ID: 3739363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenacetin O-deethylase: an activity of a cytochrome P-450 showing genetic linkage with that catalysing the 4-hydroxylation of debrisoquine?
    Kahn GC; Boobis AR; Brodie MJ; Toverud EL; Murray S; Davies DS
    Br J Clin Pharmacol; 1985 Jul; 20(1):67-76. PubMed ID: 4027138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae.
    Brian WR; Sari MA; Iwasaki M; Shimada T; Kaminsky LS; Guengerich FP
    Biochemistry; 1990 Dec; 29(51):11280-92. PubMed ID: 2271712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lidocaine metabolism by human cytochrome P-450s purified from hepatic microsomes: comparison of those with rat hepatic cytochrome P-450s.
    Imaoka S; Enomoto K; Oda Y; Asada A; Fujimori M; Shimada T; Fujita S; Guengerich FP; Funae Y
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1385-91. PubMed ID: 2262908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype.
    Barham HM; Lennard MS; Tucker GT
    Biochem Pharmacol; 1994 Apr; 47(8):1295-307. PubMed ID: 8185638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.